Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
BMEA EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Biomea Fusion, Inc.NASDAQ: BMEA
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) remains negative
Q1 FY2026 EPS (Basic) was -$0.17, compared with -$0.8 a year earlier. Trailing-twelve-month EPS (Basic) was -$0.89.
Context
- EPS (Basic) grew in size in 2 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 5 analysts of -$0.87 (+26.0%) for the fiscal year ending Dec 2026, a slowdown from the +69.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.17-366.5% QoQ
- Last fiscal yearDec 2025
- -$1.18+69.2% YoY
- LTMMar 2026
- -$0.89+75.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +78.8% | +56.2% | -22.6 pp |
| 1 year | +69.2% | +26.0% | -43.2 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (1.18) USD
- Year-over-year change
- +69.2%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.18) | +69.2% |
| FY2024 | 2024-12-31 | (3.83) | -11.3% |
| FY2023 | 2023-12-31 | (3.44) | -22.9% |
| FY2022 | 2022-12-31 | (2.80) | -60.9% |
| FY2021 | 2021-12-31 | (1.74) | — |
EPS (Basic) vs competitors
How BMEA compares with its peers on the latest reported figures
- BMEA's LTM Mar 2026 EPS (Basic) of -$0.89 is the highest of the 9 companies compared; the peer median is -$1.91.
- Its year-over-year change of +75.0% is the 2nd highest of 9, against a peer median of +15.7%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | -$0.89 | +75.0% | — | |
| LTM Mar 2026 | -$1.49 | -313.9% | — | |
| LTM Mar 2026 | -$1.65 | +33.2% | — | |
| LTM Mar 2026 | -$1.74 | +5.4% | — | |
CBUSCibus, Inc. | LTM Mar 2026 | -$1.77 | +84.8% | — |
| LTM Mar 2026 | -$2.05 | +12.2% | — | |
| LTM Mar 2026 | -$2.27 | +19.2% | — | |
| LTM Mar 2026 | -$5.98 | +39.0% | — | |
| LTM Mar 2026 | -$307.72 | -936.1% | — | |
| Peer median (excluding BMEA) | -$1.91 | +15.7% | — | |
Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 1.41M |
| Gross Profit | 0 | 0 | 0 | 0 | (1.41M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 28M | 62.71M | 102.55M | 118.09M | 61.98M |
| Selling, General & Admin | 13.67M | 20.92M | 23.59M | 25.99M | 19.33M |
| Operating Expenses | 41.67M | 83.63M | 126.14M | 144.07M | 79.9M |
| Depreciation & Amortization | 249K | 691K | 1.52M | 1.75M | 1.41M |
| EBITDA | (41.32M) | (81.14M) | (115.74M) | (136.68M) | (60.39M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (41.67M) | (83.63M) | (126.14M) | (144.07M) | (81.31M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 100K | 1.81M | 8.88M | 5.64M | 1.86M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 100K | 1.81M | 8.88M | 5.64M | 19.51M |
| Income Before Tax | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| EPS (Diluted) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| Weighted Avg Shares | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
| Weighted Avg Shares (Diluted) | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.